[PAR] QoQ Quarter Result on 30-Jun-2021 [#Q4]

Stock
[PAR] Paradigm Biopharmaceuticals Limited
Announcement Date
29-Jun-2021
Financial Year
2021
Quarter
30-Jun-2021 [#Q4]
Profit Trend
QoQ- 34.55%
YoY- -88.56%
Quarter Report
PAR's Result
PAR's Financial Summary
View:
Show?
Quarter Result
31/12/22 30/06/22 31/12/21 30/06/21 31/12/20 30/06/20 31/12/19 CAGR
Revenue 5 34 45 21 0 -826 826 -81.74%
PBT -32,643 -12,265 -26,985 -13,567 -20,730 -7,195 -5,104 85.51%
Tax -776 -0 0 0 -0 -826 826 -
NP -31,867 -12,265 -26,985 -13,567 -20,730 -7,195 -5,104 84.03%
Tax Rate - - - - - - - -
Total Cost 31,872 12,299 27,030 13,587 20,730 6,369 5,930 75.07%
Ratio Analysis
31/12/22 30/06/22 31/12/21 30/06/21 31/12/20 30/06/20 31/12/19 CAGR
NP Margin -676,590.81 -36,046.75 -59,701.41 -66,017.95 0.00 871.10 -617.95 928.48%
Per Share
31/12/22 30/06/22 31/12/21 30/06/21 31/12/20 30/06/20 31/12/19 CAGR
EPS -0.12 -0.05 -0.11 -0.06 -0.09 -0.03 -0.03 58.67%
EPS Diluted -0.12 -0.05 -0.11 -0.06 -0.09 -0.03 -0.03 58.67%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.